Status:
UNKNOWN
The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass
Lead Sponsor:
Imam Khomeini Hospital
Collaborating Sponsors:
Tehran University of Medical Sciences
Conditions:
Chronic Kidney Disease stage3
Chronic Kidney Disease stage4
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
Coronary artery disease is a major cause of death in patients with renal dysfunction Among patients who undergo coronary artery bypass grafting ,renal dysfunction is known To be a major predictor of i...
Eligibility Criteria
Inclusion
- 80\<age\>18
- ckd patients with stage 3,4
- CABG for the first time
Exclusion
- age\<18
- previous CABG (coronary artery bypass grafting)
- AKI(acute kidney injury)
- dialysis patients
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01410617
Start Date
August 1 2011
End Date
December 1 2013
Last Update
March 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tehran Herat Center
Tehran, Tehran Province, Iran, 1411713131